Lehr Martin A.
SEC CIK 1861989 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | CEO, Dir | 920.2K | $280.2K | — | 16 | 2021-10-22 | 2025-06-09 |
Most active insiders at CNTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Lehr Martin A. made no open-market trades at CNTX in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-10 | 2025-06-09 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.7 | +100.0K | 920.2K | +12% | +$70.0K |
| 2023-02-21 | 2023-02-21 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.84 | +5,823 | 159.7K | +4% | +$4,891 | |
| 2023-02-13 | 2023-02-13 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.87 | +5,606 | 153.9K | +4% | +$4,877 | |
| 2023-02-06 | 2023-02-06 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.97 | +5,040 | 148.3K | +4% | +$4,889 | |
| 2023-01-30 | 2023-01-30 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.7 | +7,027 | 143.2K | +5% | +$4,919 | |
| 2023-01-23 | 2023-01-23 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.72 | +6,839 | 136.2K | +5% | +$4,924 | |
| 2023-01-18 | 2023-01-17 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.74 | +6,783 | 129.4K | +6% | +$5,019 | |
| 2022-12-19 | 2022-12-16 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $0.74 | +20.0K | 122.6K | +19% | +$14.8K | |
| 2022-08-22 | 2022-08-19 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $1.85 | +13.0K | 102.6K | +15% | +$24.1K | |
| I | 2021-12-20 | 2021-12-16 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $3.22 | +13.0K | 820.2K | +2% | +$41.9K |
| DMAI | 2021-12-17 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | +797.2K | 210.7K | New | — |
| DAI | 2021-12-17 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $5.00 | +10.0K | 807.2K | +1% | +$50.0K |
| DAI | 2021-12-17 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | O - OTM Ex | $7.14 | +52.7K | 0 | New | +$376.1K |
| DMI | 2021-10-25 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | +797.2K | 849.9K | +1,513% | — |
| D | 2021-10-25 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | P - Purchase | $5.00 | +10.0K | 99.6K | +11% | +$50.0K |
| DI | 2021-10-25 | 2021-10-22 | CNTX | Context Therapeutics Inc. | Lehr Martin A. | CEO, Dir | O - OTM Ex | $7.14 | +52.7K | 52.7K | New | +$376.1K |
Purchase Sale Sale after option exercise All abbreviations